{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:44:56Z","timestamp":1792878296054,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:00:00Z","timestamp":1586476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["WAR 08-24; WAR 13-07; WAR 14-26"],"award-info":[{"award-number":["WAR 08-24; WAR 13-07; WAR 14-26"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013428","name":"Stichting Spieren voor Spieren","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/501100013428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Respiratory muscle weakness is an important feature of spinal muscular atrophy (SMA). Progressive lung function decline is the most important cause of mortality and morbidity in patients. The natural history of lung function in SMA has, however, not been studied in much detail.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We analysed 2098 measurements of lung function from 170 treatment-na\u00efve patients with SMA types 1c\u20134, aged 4\u201374\u2009years. All patients are participating in an ongoing population-based prevalence cohort study. We measured Forced Expiratory Volume in 1\u2009s (FEV\n                      <jats:sub>1<\/jats:sub>\n                      ), Forced Vital Capacity (FVC), and Vital Capacity (VC). Longitudinal patterns of lung function were analysed using linear mixed-effects and non-linear models. Additionally, we also assessed postural effects on results of FEV\n                      <jats:sub>1<\/jats:sub>\n                      and FVC tests. In early-onset SMA types (1c\u20133a), we observed a progressive decline of lung function at younger ages with relative stabilisation during adulthood. Estimated baseline values were significantly lower in more severely affected patients: %FEV\n                      <jats:sub>1<\/jats:sub>\n                      ranged from 42% in SMA type 1c to 100% in type 3b, %FVC 50 to 109%, and %VC 44 to 96%. Average annual decline rates also differed significantly between SMA types, ranging from \u2212\u20090.1% to \u2212\u20091.4% for FEV\n                      <jats:sub>1<\/jats:sub>\n                      , \u2212\u20090.2% to \u2212\u20091.4% for FVC, and\u2009+\u20090.2% to \u2212\u20091.7% for VC. In contrast to SMA types 1c\u20133a, we found normal values for all outcomes in later-onset SMA types 3b and 4 throughout life, although with some exceptions and based on limited available data. Finally, we found no important differences in FVC or FEV\n                      <jats:sub>1<\/jats:sub>\n                      values measured in either sitting or supine position.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our data illustrate the longitudinal course of lung function in patients with SMA, which is characterised by a progressive decline in childhood and stabilisation in early adulthood. The data do not support an additional benefit of measuring FEV\n                      <jats:sub>1<\/jats:sub>\n                      or FVC in both sitting and supine position. These data may serve as a reference to assess longer-term outcomes in clinical trials.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01367-y","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T12:02:58Z","timestamp":1586520178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Natural history of lung function in spinal muscular atrophy"],"prefix":"10.1186","volume":"15","author":[{"given":"Camiel A.","family":"Wijngaarde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther S.","family":"Veldhoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben P. A.","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A. M.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fay-Lynn","family":"Asselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelie M.","family":"W\u00f6sten-van Asperen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik H. J.","family":"Hulzebos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura P.","family":"Verweij-van den Oudenrijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Cuppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske I.","family":"Wadman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard H.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis K.","family":"van der Ent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ludo","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"key":"1367_CR1","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn MR, Wang CH. Spinal muscular atrophy. Lancet. 2008;371:2120\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(08)60921-6.","journal-title":"Lancet"},{"key":"1367_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","volume":"11","author":"E Mercuri","year":"2012","unstructured":"Mercuri E, Bertini E, Iannaccone ST. Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol. 2012;11:443\u201352. https:\/\/doi.org\/10.1016\/S1474-4422(12)70061-3.","journal-title":"Lancet Neurol"},{"key":"1367_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","volume":"28","author":"E Mercuri","year":"2018","unstructured":"Mercuri E, Finkel RS, Muntoni F, et al. Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28:103\u201315. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.005.","journal-title":"Neuromuscul Disord"},{"key":"1367_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter M, Schwarzer V, Wirth R, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70:358\u201368. https:\/\/doi.org\/10.1086\/338627.","journal-title":"Am J Hum Genet"},{"key":"1367_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/ana.25101","volume":"82","author":"SJ Kolb","year":"2017","unstructured":"Kolb SJ, Coffey CS, Yankey JW, et al. Natural history of infantile-onset spinal muscular atrophy. Ann Neurol. 2017;82:883\u201391. https:\/\/doi.org\/10.1002\/ana.25101.","journal-title":"Ann Neurol"},{"key":"1367_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.nmd.2017.11.004","volume":"28","author":"RS Finkel","year":"2018","unstructured":"Finkel RS, Mercuri E, Meyer OH, et al. Diagnosis and management of spinal muscular atrophy: part 2: pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28:197\u2013207. https:\/\/doi.org\/10.1016\/j.nmd.2017.11.004.","journal-title":"Neuromuscul Disord"},{"key":"1367_CR7","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377:1723\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1702752.","journal-title":"N Engl J Med"},{"key":"1367_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1706198.","journal-title":"N Engl J Med"},{"key":"1367_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1212\/WNL.0000000000006026","volume":"91","author":"BT Darras","year":"2018","unstructured":"Darras BT, De Vivo DC. Precious SMA natural history data: a benchmark to measure future treatment successes. Neurology. 2018;91:337\u20139. https:\/\/doi.org\/10.1212\/WNL.0000000000006026.","journal-title":"Neurology"},{"key":"1367_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/088307389400900321","volume":"9","author":"FJ Samaha","year":"1994","unstructured":"Samaha FJ, Buncher CR, Russman BS, et al. Pulmonary function in spinal muscular atrophy. J Child Neurol. 1994;9:326\u20139. https:\/\/doi.org\/10.1177\/088307389400900321.","journal-title":"J Child Neurol"},{"key":"1367_CR11","first-page":"15","volume":"45","author":"L-C Lin","year":"2004","unstructured":"Lin L-C, Jong Y-J. Pulmonary function assessment in patients with spinal muscular atrophy type II and type III. Acta Paediatr Taiwan. 2004;45:15\u20138 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15264700.","journal-title":"Acta Paediatr Taiwan"},{"key":"1367_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/PHM.0b013e31824fa5dd","volume":"91","author":"JR Bach","year":"2012","unstructured":"Bach JR, Tuccio MC, Khan U, et al. Vital capacity in spinal muscular atrophy. Am J Phys Med Rehabil. 2012;91:487\u201393. https:\/\/doi.org\/10.1097\/PHM.0b013e31824fa5dd.","journal-title":"Am J Phys Med Rehabil"},{"key":"1367_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ejpn.2013.04.004","volume":"17","author":"S Khirani","year":"2013","unstructured":"Khirani S, Colella M, Caldarelli V, et al. Longitudinal course of lung function and respiratory muscle strength in spinal muscular atrophy type 2 and 3. Eur J Paediatr Neurol. 2013;17:552\u201360. https:\/\/doi.org\/10.1016\/j.ejpn.2013.04.004.","journal-title":"Eur J Paediatr Neurol"},{"key":"1367_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201004","volume":"13","author":"A Chabanon","year":"2018","unstructured":"Chabanon A, Seferian AM, Daron A, et al. Prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study. PLoS One. 2018;13:e0201004. https:\/\/doi.org\/10.1371\/journal.pone.0201004.","journal-title":"PLoS One"},{"key":"1367_CR15","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/j.nmd.2019.06.337","volume":"29","author":"F Trucco","year":"2019","unstructured":"Trucco F, Ridout D, Finkel R, et al. Respiratory function in SMA type 2 and non-ambulant SMA type 3, longitudinal data from the international SMA consortium (iSMAc). Neuromuscul Disord. 2019;29:S131\u20132. https:\/\/doi.org\/10.1016\/j.nmd.2019.06.337.","journal-title":"Neuromuscul Disord"},{"key":"1367_CR16","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.pmr.2008.04.006","volume":"19","author":"P Kaufmann","year":"2008","unstructured":"Kaufmann P, Iannaccone ST. Clinical trials in spinal muscular atrophy. Phys Med Rehabil Clin N Am. 2008;19:653\u201360, xii. https:\/\/doi.org\/10.1016\/j.pmr.2008.04.006.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"1367_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneur.59.9.1445","volume":"59","author":"ST Iannaccone","year":"2002","unstructured":"Iannaccone ST. Outcome measures for pediatric spinal muscular atrophy. Arch Neurol. 2002;59:1445\u201350 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12223032.","journal-title":"Arch Neurol"},{"key":"1367_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/jnnp-2016-314292","volume":"88","author":"RI Wadman","year":"2017","unstructured":"Wadman RI, Stam M, Gijzen M, et al. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0\u20134. J Neurol Neurosurg Psychiatry. 2017;88:365\u20137. https:\/\/doi.org\/10.1136\/jnnp-2016-314292.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1367_CR19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/ene.13534","volume":"25","author":"RI Wadman","year":"2018","unstructured":"Wadman RI, Wijngaarde CA, Stam M, et al. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4. Eur J Neurol. 2018;25:512\u20138. https:\/\/doi.org\/10.1111\/ene.13534.","journal-title":"Eur J Neurol"},{"key":"1367_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"1367_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archneur.1995.00540290108025","volume":"52","author":"K Zerres","year":"1995","unstructured":"Zerres K, Rudnik-Schoneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications. Arch Neurol. 1995;52:518\u201323.","journal-title":"Arch Neurol"},{"key":"1367_CR22","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1093\/brain\/awt284","volume":"136","author":"AR Foley","year":"2013","unstructured":"Foley AR, Quijano-Roy S, Collins J, et al. Natural history of pulmonary function in collagen VI-related myopathies. Brain. 2013;136:3625\u201333. https:\/\/doi.org\/10.1093\/brain\/awt284.","journal-title":"Brain"},{"key":"1367_CR23","first-page":"407","volume":"45","author":"GM Vilke","year":"2000","unstructured":"Vilke GM, Chan TC, Neuman T, et al. Spirometry in normal subjects in sitting, prone, and supine positions. Respir Care. 2000;45:407\u201310 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10780036.","journal-title":"Respir Care"},{"key":"1367_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338. https:\/\/doi.org\/10.1183\/09031936.05.00034805.","journal-title":"Eur Respir J"},{"key":"1367_CR25","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40:1324\u201343. https:\/\/doi.org\/10.1183\/09031936.00080312.","journal-title":"Eur Respir J"},{"key":"1367_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.amc.2004.10.034","volume":"169","author":"H Kano","year":"2005","unstructured":"Kano H, Nakata H, Martin CF. Optimal curve fitting and smoothing using normalized uniform B-splines: a tool for studying complex systems. Appl Math Comput. 2005;169:96\u2013128. https:\/\/doi.org\/10.1016\/j.amc.2004.10.034.","journal-title":"Appl Math Comput"},{"key":"1367_CR27","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2017","unstructured":"Core Team R. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2017. https:\/\/www.r-project.org\/."},{"key":"1367_CR28","doi-asserted-by":"publisher","unstructured":"Bates D, M\u00e4chler M, Bolker B, et al. Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw. 2015;67. https:\/\/doi.org\/10.18637\/jss.v067.i01.","DOI":"10.18637\/jss.v067.i01"},{"key":"1367_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis; 2016."},{"key":"1367_CR30","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1212\/WNL.0b013e318271f7e4","volume":"79","author":"P Kaufmann","year":"2012","unstructured":"Kaufmann P, McDermott MP, Darras BT, et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology. 2012;79:1889\u201397. https:\/\/doi.org\/10.1212\/WNL.0b013e318271f7e4.","journal-title":"Neurology"},{"issue":"Suppl","key":"1367_CR31","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.1542\/peds.2008-2952K","volume":"123","author":"MK Schroth","year":"2009","unstructured":"Schroth MK. Special considerations in the respiratory management of spinal muscular atrophy. Pediatrics. 2009;123(Suppl):S245\u20139. https:\/\/doi.org\/10.1542\/peds.2008-2952K.","journal-title":"Pediatrics"},{"key":"1367_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1469-8749.2002.tb00847.x","volume":"44","author":"BF Steffensen","year":"2002","unstructured":"Steffensen BF, Lyager S, Werge B, et al. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol. 2002;44:623\u201332 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12227617.","journal-title":"Dev Med Child Neurol"},{"key":"1367_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.nmd.2009.11.008","volume":"20","author":"U Werlauff","year":"2010","unstructured":"Werlauff U, Steffensen BF, Bertelsen S, et al. Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients. Neuromuscul Disord. 2010;20:34\u201343. https:\/\/doi.org\/10.1016\/j.nmd.2009.11.008.","journal-title":"Neuromuscul Disord"},{"key":"1367_CR34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/088307388900400208","volume":"4","author":"E Rodillo","year":"1989","unstructured":"Rodillo E, Marini ML, Heckmatt JZ, et al. Scoliosis in spinal muscular atrophy: review of 63 cases. J Child Neurol. 1989;4:118\u201323. https:\/\/doi.org\/10.1177\/088307388900400208.","journal-title":"J Child Neurol"},{"key":"1367_CR35","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1097\/00002060-199509001-00009","volume":"74","author":"GT Carter","year":"1995","unstructured":"Carter GT, Abresch RT, Fowler WMJ, et al. Profiles of neuromuscular diseases. Spinal muscular atrophy. Am J Phys Med Rehabil. 1995;74:S150\u20139.","journal-title":"Am J Phys Med Rehabil"},{"key":"1367_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1378\/chest.14-0166","volume":"146","author":"LM Gauld","year":"2014","unstructured":"Gauld LM, Keeling LA, Shackleton CE, et al. Forced oscillation technique in spinal muscular atrophy. Chest. 2014;146:795\u2013803. https:\/\/doi.org\/10.1378\/chest.14-0166.","journal-title":"Chest"},{"key":"1367_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1378\/chest.126.3.831","volume":"126","author":"C Ioos","year":"2004","unstructured":"Ioos C, Leclair-Richard D, Mrad S, et al. Respiratory capacity course in patients with infantile spinal muscular atrophy. Chest. 2004;126:831\u20137. https:\/\/doi.org\/10.1378\/chest.126.3.831.","journal-title":"Chest"},{"key":"1367_CR38","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archneurol.2010.373","volume":"68","author":"P Kaufmann","year":"2011","unstructured":"Kaufmann P, McDermott MP, Darras BT, et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol. 2011;68:779\u201386. https:\/\/doi.org\/10.1001\/archneurol.2010.373.","journal-title":"Arch Neurol"},{"key":"1367_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1136\/adc.2009.177832","volume":"96","author":"M Chatwin","year":"2011","unstructured":"Chatwin M, Bush A, Simonds AK. Outcome of goal-directed non-invasive ventilation and mechanical insufflation\/exsufflation in spinal muscular atrophy type I. Arch Dis Child. 2011;96:426\u201332. https:\/\/doi.org\/10.1136\/adc.2009.177832.","journal-title":"Arch Dis Child"},{"key":"1367_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ppul.23172","volume":"50","author":"OH Mayer","year":"2015","unstructured":"Mayer OH, Finkel RS, Rummey C, et al. Characterization of pulmonary function in Duchenne muscular dystrophy. Pediatr Pulmonol. 2015;50:487\u201394. https:\/\/doi.org\/10.1002\/ppul.23172.","journal-title":"Pediatr Pulmonol"},{"key":"1367_CR41","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/WNL.0000000000007742","volume":"93","author":"CA Wijngaarde","year":"2019","unstructured":"Wijngaarde CA, Brink RC, de Kort FAS, et al. Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy. Neurology. 2019;93:e149\u201358 http:\/\/www.neurology.org\/lookup\/doi\/10.1212\/WNL.0000000000007742.","journal-title":"Neurology"},{"key":"1367_CR42","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073807305673","volume":"22","author":"BS Russman","year":"2007","unstructured":"Russman BS. Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol. 2007;22:946\u201351. https:\/\/doi.org\/10.1177\/0883073807305673.","journal-title":"J Child Neurol"},{"key":"1367_CR43","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22:1027\u201349. https:\/\/doi.org\/10.1177\/0883073807305788.","journal-title":"J Child Neurol"},{"key":"1367_CR44","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1378\/chest.108.3.779","volume":"108","author":"S Lyager","year":"1995","unstructured":"Lyager S, Steffensen B, Juhl B. Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy. Chest. 1995;108:779\u201385 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7656633.","journal-title":"Chest"},{"key":"1367_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0022-510X(96)00284-5","volume":"146","author":"K Zerres","year":"1997","unstructured":"Zerres K, Rudnik-Sch\u00f6neborn S, Forrest E, et al. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. J Neurol Sci. 1997;146:67\u201372.","journal-title":"J Neurol Sci"},{"key":"1367_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/0883073811420152","volume":"27","author":"X Ge","year":"2012","unstructured":"Ge X, Bai J, Lu Y, et al. The natural history of infant spinal muscular atrophy in China: a study of 237 patients. J Child Neurol. 2012;27:471\u20137. https:\/\/doi.org\/10.1177\/0883073811420152.","journal-title":"J Child Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01367-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01367-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01367-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T19:27:07Z","timestamp":1617996427000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01367-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,10]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1367"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01367-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,10]]},"assertion":[{"value":"13 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Medical Ethics Committee of the University Medical Centre Utrecht (No. 09\u2013307\/NL29692.041.09). Written informed consent was obtained from all participants and\/or their parents in case of minors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"C.A.W., E.S.V., R.P.A.v.E., M.S., L.A.M.O., F.A., R.M.W.v.A., E.H.J.H., L.P.V.v.d.O, I.C., R.I.W., and W.L.v.d.P. declare no relevant financial or other conflicts of interest. B.B. receives research support from the Prinses Beatrix Spierfonds and Stichting Spieren voor Spieren. His employer receives fees for consultancy services to Cytokinetics and Scholar Rock. K.v.d.E. receives research grants from GSK, Nutricia, TEVA, Gilead, Vertex, ProQR, Proteostasis, and Galapagos, all unrelated to the submitted work. L.H.v.d.B. serves on scientific advisory boards for the Prinses Beatrix Spierfonds, Thierry Latran Foundation, Biogen Idec, and Cytokinetics; has received an educational grant from Baxter International Inc.; serves on the editorial board of Amyotrophic Lateral Sclerosis and Journal of Neurology, Neurosurgery and Psychiatry; and received research support from the Prinses Beatrix Spierfonds, Netherlands ALS Foundation, The European Community\u2019s Health Seventh Framework Programme (grant agreement no. 259867) and The Netherlands Organization for Health Research and Development [Vici Scheme, JPND (SOPHIA, STRENGTH)], all unrelated to the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}